Being overweight or obese is often the root cause of chronic diseases, including: Cardiovascular disease Type 2 diabetes Stroke High blood pressure High cholesterol Fatty liver Certain types of cancers Osteoarthritis Sleep apnea Hormone disorders, including insulin resistance Alzheimers or dementia Depression and other mood disorders Joint pain A landmark clinical trial published in The New England Journal of Medicine in 2021 found that semaglutide led to a 15% reduction in body weight, on average
Ozempic is approved for the treatment of type 2 diabetes, while Semaglutide is approved for the treatment of obesity as defined by body mass index above 30
These hormones help regulate blood sugar levels, suppress appetite, and improve metabolic function
The side effects at this dose are also the most pronounced, with nausea affecting approximately 44 percent of participants in trials
This may be a physician, nurse practitioner, or physician assistant